Joint Formulary & PAD

Beclometasone (Clenil Modulite) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

PAD Profile

ChemicalSubstance :
Beclometasone (Clenil Modulite)
Indication :
Asthma
Group Name :
ICS
Keywords :
Inhaled corticosteroids, ICS, respiratory, asthmatics,
Brand Names Include :
Important Information :

Children only - ICS alone not recommended in adults with asthma.

First line ICS in children.

Prescribe by BRAND

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
8

Committee Recommendations (1)

Chiesi has advised that final UK supply of Clenil Modulite 50 micrograms, Clenil Modulite 250 micrograms and Atimos 12 micrograms will take place in October 2026, with remaining stock expected to be exhausted by mid-November 2026. 
Specific advice on suitable alternatives is given, for each patient cohort, in the document  to the left (Clenil and Atimos discontinuation advice for practices)

Other Indications

Below are listed other indications that Beclometasone (Clenil Modulite) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Asthma.